Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 11, 1980
Non-specific cross-reacting antigen serum concentration in myeloid leukemiasN Frénoy, P BurtinComptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|November 24, 1975
[Molecular weight of human alpha2-H-ferroglobulin subunits. Comparison with molecular weight of ferritin subunits]N Frénoy, C Rimbant, D BuffeAnticancer Research|November 1, 1987
Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human seraN Frénoy, J Schauffler, A Cahour, et al.European Journal of Haematology|November 10, 2000
Real-time quantitation of bcr-abl transcripts in haematological malignanciesR Saffroy, A Lemoine, P Brézillon, et al.British Journal of Cancer|November 1, 1982
An investigation of factors influencing serum NCA (non-specific cross-reacting antigen) level in patients with chronic myeloid leukaemiaN Frénoy, M Ben-Bunant, C Berruel, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 2, 2010
Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphomaD Machover, B Delmas-Marsalet, S C Misra, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphomaD Machover, B Delmas-Marsalet, S C Misra, et al.Pageof 1